MediciNova, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US58468P2065
USD
1.55
0.08 (5.44%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Oramed Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc.
Ocugen, Inc.
Nektar Therapeutics
Esperion Therapeutics, Inc.
ProQR Therapeutics NV
Talaris Therapeutics, Inc.
Abeona Therapeutics, Inc.
Inovio Pharmaceuticals, Inc.
MediciNova, Inc.
Reviva Pharmaceuticals Holdings, Inc.
Why is MediciNova, Inc. ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is MediciNova, Inc. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
MediciNova, Inc.
-32.61%
0.22
65.76%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
2.47%
EBIT Growth (5y)
-1.68%
EBIT to Interest (avg)
-12.38
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.73
Sales to Capital Employed (avg)
0.01
Tax Ratio
0.05%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.71%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.39
EV to EBIT
-2.57
EV to EBITDA
-2.58
EV to Capital Employed
2.42
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-94.04%
ROE (Latest)
-22.35%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
NET SALES(9M)

At USD 0.13 MM has Grown at inf%

NET PROFIT(HY)

Higher at USD -6.15 MM

RAW MATERIAL COST(Y)

Fallen by -980% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 2 times

-8What is not working for the Company
ROCE(HY)

Lowest at -22.66%

CASH AND EQV(HY)

Lowest at USD 70.83 MM

DEBT-EQUITY RATIO (HY)

Highest at -72.47 %

OPERATING PROFIT(Q)

Lowest at USD -3.6 MM

PRE-TAX PROFIT(Q)

Lowest at USD -3.28 MM

NET PROFIT(Q)

Lowest at USD -3.28 MM

EPS(Q)

Lowest at USD -0.07

Here's what is working for MediciNova, Inc.
Net Sales
At USD 0.13 MM has Grown at inf%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (USD MM)

Debtors Turnover Ratio
Highest at 2 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -980% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for MediciNova, Inc.
Operating Profit
Lowest at USD -3.6 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -3.28 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -3.28 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

EPS
Lowest at USD -0.07
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Cash and Eqv
Lowest at USD 70.83 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at -72.47 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio